We are committed to providing quality and comprehensive training and supervision to support therapy providers in delivering safe, ethical care within MAPS-sponsored study protocols. For the purpose of protecting the safety and welfare of participants, the MAPS Code of Ethics for Psychedelic Psychotherapy outlines ethical principles governing treatment decisions made by providers delivering psychedelic psychotherapy within a MAPS protocol. The Code of Ethics provides the foundation for MAPS’ culture of safety, guiding and informing the practice of therapy within MAPS protocols.
Follow along as we explore the importance of cultivating safety in psychedelic therapy in this new article published in the MAPS Bulletin.
*LINK IN BIO*
MAPS Bulletin 2022: Vol 32, No. 1 is now available! This edition of the MAPS Bulletin features 14 new educational articles about varying psychedelic topics from leading experts and cover art by Trey Brasher (@Jarma_Sutra).
*LINK IN BIO*
Congratulations to the 300+ clinicians and counselors who recently completed the four-month MDMA Therapy Training Program online course! This cohort represented the largest of its kind and is part of an effort to train thousands of therapists, social workers, nurses, doctors, chaplains, and other care providers in the therapeutic modality of MDMA-assisted therapy.
Stay tuned for upcoming announcements about the MDMA Therapy Training Program!
Pictured: August 2019 MDMA Therapy Training Program Cohort
*LINK IN BIO*
Treating #PTSD With MDMA-Assisted #Therapy
The investigators of MAPS' first Phase 3 trial of MDMA-assisted therapy for PTSD observed no serious safety or tolerability issues in the group that received MDMA-assisted therapy. MDMA did not increase the risk of suicidal thoughts or behaviors and did not increase cardiovascular risk or abuse potential relative to therapy with placebo. As expected from previous #ClinicalTrials, temporary increases in blood pressure and pulse were observed during MDMA sessions. Adverse events such as muscle tightness, decreased appetite, nausea, sweating, and feeling cold were transient.
The statistically significant results and excellent safety record suggest that MDMA-assisted therapy will be an effective treatment for severe, chronic PTSD.
[Part 3 of 6]
*LINK IN BIO*
#Psychedelic #Psychedelics #PsychedelicNews #PsychedelicScience #Science #PsychedelicResearch #Research #PsychedelicTherapy #PsychedelicEducation #Education #Consciousness #MassMentalHealth #MentalHealth #MDMATherapy #MDMAPTSD
This spring, researchers from @ImperialCollege London's Centre for #Psychedelic Research published the results of "the largest placebo-controlled trial on #psychedelics to date," a self-blinding #microdose study.
Positive changes were observed in psychological measures among participants in the #microdosing group; however, participants in the placebo group showed similar benefits. Differences in the data were driven by which psychedelic substance people thought they were taking, rather than what they actually took, raising questions about the role of expectations and beliefs in the medicinal use of psychedelics.
*LINK IN BIO*
#PsychedelicScience #Science #PsychedelicResearch #Research #PsychedelicTherapy #Therapy #PsychedelicEducation #Education #Consciousness #MassMentalHealth #MentalHealth